Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
|Variant||KMT2A - TET1|
|Gene Variant Descriptions||KMT2A-TET1 results from the fusion of KMT2A and TET1 (PMID: 12124344, PMID: 12646957). KMT2A-TET1 has been identified in acute myeloid leukemia (PMID: 12124344, PMID: 12646957), B-cell precursor acute lymphoblastic leukemia (PMID: 19144982), and T-cell lymphoblastic lymphoma (PMID: 24323992), but has not been biochemically characterized and therefore, the effect on protein function is unknown (PubMed, Sep 2019).|
|Associated Drug Resistance|
|Molecular Profile||Protein Effect||Treatment Approaches|
|KMT2A - TET1||unknown|
|Molecular Profile||Indication/Tumor Type||Response Type||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|